Casdin Capital, LLC Burning Rock Biotech LTD Transaction History

Casdin Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$26.14 - $37.45 $22.1 Million - $31.7 Million	-847,150 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$23.5 - $39.58 $25.3 Million - $42.5 Million	-1,075,000 Reduced 55.93%	847,150 $22.8 Million
Q3 2020 Nov 16, 2020	BUY	$19.07 - $29.61 $3.65 Million - $5.67 Million	191,364 Added 11.06%	1,922,150 $48.2 Million
Q2 2020 Aug 14, 2020	BUY	$23.21 - $31.43 $40.2 Million - $54.4 Million	1,730,786 New	1,730,786 $46.7 Million

21.2K

Ticker BNR
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 105,188,000
Market Cap $736M
Description
Burning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based cancer therapy selection and p...

Get notified when there are updates to the investment portfolio of Casdin Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Casdin Capital, LLC with notifications on news.